Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1177339.RAo3eZOKiC-qES2oDVtlxbugenrh3i-wWAjG8yRdcibE4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1177339.RAo3eZOKiC-qES2oDVtlxbugenrh3i-wWAjG8yRdcibE4130_assertion type Assertion NP1177339.RAo3eZOKiC-qES2oDVtlxbugenrh3i-wWAjG8yRdcibE4130_head.
- NP1177339.RAo3eZOKiC-qES2oDVtlxbugenrh3i-wWAjG8yRdcibE4130_assertion description "[RAS-RAF-MEK-ERK and PI3K-AKT pathways form a significant cascade for potential molecular target therapy in advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1177339.RAo3eZOKiC-qES2oDVtlxbugenrh3i-wWAjG8yRdcibE4130_provenance.
- NP1177339.RAo3eZOKiC-qES2oDVtlxbugenrh3i-wWAjG8yRdcibE4130_assertion evidence source_evidence_literature NP1177339.RAo3eZOKiC-qES2oDVtlxbugenrh3i-wWAjG8yRdcibE4130_provenance.
- NP1177339.RAo3eZOKiC-qES2oDVtlxbugenrh3i-wWAjG8yRdcibE4130_assertion SIO_000772 24774510 NP1177339.RAo3eZOKiC-qES2oDVtlxbugenrh3i-wWAjG8yRdcibE4130_provenance.
- NP1177339.RAo3eZOKiC-qES2oDVtlxbugenrh3i-wWAjG8yRdcibE4130_assertion wasDerivedFrom befree-2016 NP1177339.RAo3eZOKiC-qES2oDVtlxbugenrh3i-wWAjG8yRdcibE4130_provenance.
- NP1177339.RAo3eZOKiC-qES2oDVtlxbugenrh3i-wWAjG8yRdcibE4130_assertion wasGeneratedBy ECO_0000203 NP1177339.RAo3eZOKiC-qES2oDVtlxbugenrh3i-wWAjG8yRdcibE4130_provenance.